Enfusion, Inc (ENFN) Misses Q1 EPS by 13c

Enfusion, Inc (NYSE: ENFN) reported Q1 EPS of ($0.10), $0.13 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $34.1 million versus the consensus estimate of $33.03 million.

GUIDANCE:

Enfusion, Inc sees FY2022 revenue of $148.1-151.1 million, versus the consensus of $148.5 million.

For earnings history and earnings-related data on Enfusion, Inc (ENFN) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M